Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020
oleh: Oliver Van Oekelen, Nicole Birrer, William Wesson, Vincent L. Galate, Edward R. Scheffer Cliff, Aaron M. Goodman, Al-Ola Abdallah, Rajshekhar Chakraborty, Vinay Prasad, Ghulam Rehman Mohyuddin
| Format: | Article |
|---|---|
| Diterbitkan: | Nature Publishing Group 2022-11-01 |
Deskripsi
No description available for this item.